showed that serum CTRP4 were decreased in T2DM patients with Carotid atherosclerosis (CAS) compared to those without CAS, indicating that serum CTRP4 levels were negatively related to the risk of CAS in T2DM (21). This evidence concerns the gene C1QTNF4 and carotid atherosclerosis.